-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - Strength of evidence domains for studies comparing lacosamide with placebo in terms
of quality of life … Strength of evidence domains for studies comparing 8% capsaicin patch with placebo
in terms of pain … Neurology. 1998
Jun;50(6):1842-6. PMID: 9633738.
53. . … J Am Podiatr Med
Assoc. 1991 Jun;81(6):288-93. doi:
10.7547/87507315-81-6-288. … Lancet. 1988 Jan 2-
9;1(8575-6):9-11. PMID: 2891940.
60.
-
effectivehealthcare.ahrq.gov/products/migraine-emergency/research-protocol
July 18, 2011 - of the randomized controlled trials and nonrandomized controlled trials. 20 The tool examines six domains … The overall assessment is based on the responses to individual domains. … If one or more individual domains are assessed as having a high risk of bias, the overall score will … Cephalalgia 2006;26(6):684-90. PMID: 16686907. … Rev Neurol (Paris) 2005;161(6-7):658-60.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
December 17, 2013 - literature, using an instrument we develop based upon the Cochrane Risk of Bias tool.11
The seven domains … outcome data, selective reporting, and other sources of bias (i.e., problems not
covered by other domains … to sustained disease progression) within each
comparison will be evaluated based on four required domains … an estimate).16 A fifth domain, reporting bias, will be assessed when
SOE based upon the first four domains … Q Rev Biol.
2011 Dec;86(4):287-321.
6. Daumer M, Neuhaus A, Herbert J, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
July 18, 2011 - the randomized controlled trials and nonrandomized controlled trials.
20
The tool examines six
domains … The overall assessment is based on the responses to individual domains. … If one or
more individual domains are assessed as having a high risk of bias, the overall score will … for Effectiveness and
Comparative Effectiveness Reviews.
29
We will examine the following four domains … Rev Neurol (Paris) 2005;161(6-7):658-60.
17.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-protocol.pdf
January 01, 2023 - Prioritization Report
for additional details.1
HROs are organizations that operate in complex, high-hazard domains … When assessing RCTs, we will use the 7
items in the Cochrane Collaboration’s tool that cover the domains … PMID: 37838378.
6. Vogus TJ, Sutcliffe KM, Weick KE. … Crit Care.
2011;15(6):314. PMID: 22188677.
8. Veazie S, Peterson K, Bourne D. … HROs are organizations that operate in complex, high-hazard domains for extended periods without serious
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
May 18, 2011 - Time Period KQs 1–6: 2000–present.
Setting KQs 1–6: All settings. … KQs 3–6: Any study design. … Effectiveness and Comparative Effectiveness Reviews.
17
The grade will be based on four
major domains … Additional domains—such as dose-response association, plausible confounding, strength
of association … applicability for each outcome (including harms) will be performed
separately from assessments of the other domains
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_disposition-comments.pdf
January 01, 2012 - Peer reviewer #6 Methods The inclusion and exclusion criteria are justifiable. … We have added a table describing EPC
definitions of these domains to the Methods
section. … We have added a table describing EPC
definitions of these domains to the Methods
section. … completed 6 months of treatment rather than 12 months after
patient completed 6 months of treatment … We have added a table describing EPC
definitions of these domains to the Methods
section.
-
effectivehealthcare.ahrq.gov/products/fecal-incontinence/research-protocol
December 01, 2014 - percent of residents with severe cognitive impairment have experienced FI. 4 Monthly FI occurs in 6 … Colorectal Dis 2012; Jun;14(6):e297-304. PMID: 22356165.
Glasgow SC, Lowry AC. … Medical care 1992; Jun;30(6):473-83. PMID: 1593914.
Rockwood TH, Church JM, Fleshman JW, et al. … Dis Colon Rectum 2001; Jun;44(6):799-805. PMID: 11391139.
Williams A. … No
Intervention poorly described
6.
Is the selection of the comparison group appropriate?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
November 30, 2014 - Moderate risk of bias will
be assigned to studies that are challenged across several of the domains … Accessed 4/18/22014.
6. Norton C, Cody June D. … Accessed 6.
9. Cazemier M, Felt-Bersma RJ, Mulder CJ. … Medical care
1992; Jun;30(6):473-83. PMID: 1593914.
28. … Dis
Colon Rectum 2001; Jun;44(6):799-805. PMID:
11391139.
35. Williams A.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-screening/research-protocol
May 18, 2011 - Time Period
KQs 1–6: 2000–present.
Setting
KQs 1–6: All settings. … KQs 3–6: Any study design. … for Effectiveness and Comparative Effectiveness Reviews . 17 The grade will be based on four major domains … Additional domains—such as dose-response association, plausible confounding, strength of association, … applicability for each outcome (including harms) will be performed separately from assessments of the other domains
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_executive.pdf
July 01, 2012 - Overall costs
6. … Less than 6 months longitudinal
followup. … Additional
domains, to be used when appropriate, are coherence,
dose-response association, impact of … These domains were considered
qualitatively, and a summary rating was assigned, after
discussion by … PMID:
15677789.
6. Nolte E, McKee CM.
-
effectivehealthcare.ahrq.gov/products/multiple-sclerosis/research-protocol
December 17, 2013 - literature, using an instrument we develop based upon the Cochrane Risk of Bias tool. 11 The seven domains … incomplete outcome data, selective reporting, and other sources of bias (i.e., problems not covered by other domains … time to sustained disease progression) within each comparison will be evaluated based on four required domains … estimate). 16 A fifth domain, reporting bias, will be assessed when SOE based upon the first four domains … - interrupt$.mp.
7 - stop$.mp.
8 - 2 or 3 or 4 or 5 or 6 or 7
9 - 1 and 8
KQ1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - In addition, risk of glucose intolerance and
obesity in childhood is associated with GDM.
6
Much … The overall assessment is based on the responses to individual domains. … Diabetes Care 2010;33:964–8.
6. Dodd J, Crowther C, Antoniou G, et al. … Obstet Gynecol 2004;103(6):1229–34.
8. … (gestation$ adj2 (diabet$ or DM or glucose intoleran$ or insulin resistan$)).mp.
6.
-
effectivehealthcare.ahrq.gov/products/management-infantile-epilepsy/research-protocol
February 03, 2021 - The rating will be based on considering all of the domains listed below. … March 7, 2021
Criteria for Study Inclusion and Exclusion, Study Design Criterion #6
Allow outcome … topiramate OR valproate OR 'valproate semisodium' OR 'valproic acid' OR vigabatrin OR zonisamide
6 … Pharmacology)
#5 AND #12 AND #13
15
Combine sets
(KQ2 Diet, Surgery, Brain Stimuation)
(#6 … (KQ3 Harms)
#9 AND #12 AND #13
17
Combine sets
(CQ1 Parental Preferences)
((#5 OR #6
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
June 01, 2016 - The expected clearance rate
for placebo or observation was 6 percent (95% BCI: 1%
to 11%). … steroids more
effective
Clearance rate:
Steroids 43%
(95% BCI, 21% to 66%)
Observation/placebo 6% … steroids
more effective
Clearance rate:
Steroids 58%
(95% BCI, 22% to 93%)
Observation/placebo 6% … *The overall evidence grade was assessed based on the ratings for the following domains: study limitations … Other domains that were
considered, as appropriate, included dose-response association, plausible confounding
-
effectivehealthcare.ahrq.gov/products/dementia-agitation-aggression/research-protocol
November 13, 2014 - The seven domains included in this tool include sequence generation, allocation concealment, blinding … International Journal of Geriatric Psychiatry. 2006 Oct;21(10):972-6. PMID 16955429. … Current Treatment Options in Neurology. 2013 Dec;15(6):765-85. PMID 24136714.
Volicer L. … Journal of Clinical Psychiatry. 2008 Jun;69(6):889-98. PMID 18494535.
A. P. A. … The Journal of head trauma rehabilitation. 1999;14(1):91-6.
Rosen J, Burgio L, Kollar M, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0376-140408.pdf
November 06, 2013 - Intervention(s):
Psychiatric hospitalization: ultra-short (1 to 4 days), short (5 to 6), longer ( … depression, is a
long-term illness involving substantial functional impairment over multiple symptom domains
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-2010_research-protocol.pdf
January 01, 2010 - Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 6, … For RCTs, the fundamental domains will include: adequate
sequence generation, allocation concealment … Effectiveness and Comparative Effectiveness Reviews,
10
which emphasizes the following four
major domains … comparison of interest will be given an overall evidence grade based on the ratings for the
individual domains … Accessed February
4, 2011.
6. Clark SL, Belfort MA, Hankins GD, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-268-racial-disparities-health-healthcare-executive-summary.pdf
December 01, 2023 - disparities) and
thereby contribute to or exacerbate unequal health outcomes (health disparities).4-6 … Using this tool, ROB ratings on each of seven
domains are combined to generate an overall rating of … In six studies, ROB ratings for
individual domains of bias changed because of the equity-based signaling … Lancet.
2020;396(10257):1125-8. doi:
10.1016/s0140-6736(20)32076-6. PMID:
33038972.
3. … PMID: 31649194.
6. Amutah C, Greenidge K, Mante A, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol.pdf
May 01, 2023 - Bias tool 2.033 as low risk, some concerns (moderate risk), or high risk for each of the
following domains … ROBINS-I) tool34 as low, moderate, serious, critical, or no information
for each of the following domains … ROBINS-E) tool35 as
low, moderate, serious, critical, or no information for each of the following domains … strength of evidence for outcomes within each comparison will be
evaluated based on five required domains … Dec 2009;90(6):1509-16.
doi:10.3945/ajcn.2009.27601
16.